Kathryn J. Martires

Antitumorigenic potential of STAT3 alternative splicing modulation

Francesca Zammarchi, Elisa de Stanchina, Eirini Bournazou et al. · Proceedings of the National Academy of Sciences · 2011 · 171 citations · Full text

Cell Death, Cancer Biology, Splicing Variant +17

Prospective evaluation of dermatologic surgery complications including patients on multiple antiplatelet and anticoagulant medications

Jeremy S. Bordeaux, Kathryn J. Martires, Dori Goldberg et al. · Journal of the American Academy of Dermatology · 2011 · 158 citations

Thrombosis, Multiple Antiplatelet, Blood Platelet +9

Psoriasis and the Risk of Depression in the US Population

Brandon E. Cohen, Kathryn J. Martires, Roger S. Ho · JAMA Dermatology · 2015 · 148 citations

Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease

Kathryn J. Martires, Kristin Baird, Seth M. Steinberg et al. · Blood · 2011 · 119 citations · Full text

Prognostic Factors, Treatment, and Survival in Dermatofibrosarcoma Protuberans

Maressa C. Criscito, Kathryn J. Martires, Jennifer Stein · JAMA Dermatology · 2016 · 84 citations · Full text